Evidence map›Paper›PMID 32610297›Full record

ArticleNeurosurgical focus2020

Clinical applications of neurochemical and electrophysiological measurements for closed-loop neurostimulation.

J Blair Price, Aaron E Rusheen, Abhijeet S Barath, Juan M Rojas Cabrera, Hojin Shin, Su-Youne Chang, Christopher J Kimble, Kevin E Bennet, Charles D Blaha, Kendall H Lee and 1 more

Abstract read
In one paragraph

Article in Neurosurgical focus, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Neuromodulation in Small Animal fMRI.Journal of magnetic resonance imaging : JMRI · 2025
    Review
  7. Review
  8. Review
  9. Review
  10. The evolution of neuromodulation for chronic stroke: From neuroplasticity mechanisms to brain-computer interfaces.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2024
    Review
  11. Review
  12. Computational Neurosurgery in Deep Brain Stimulation.Advances in experimental medicine and biology · 2024
    Review
  13. Article
  14. Article
  15. Review
  16. Biomarkers for Deep Brain Stimulation in Animal Models of Depression.Neuromodulation : journal of the International Neuromodulation Society · 2022
    Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

J Blair Price1Department of Neurologic Surgery.
Aaron E Rusheen1Department of Neurologic Surgery.
Abhijeet S Barath1Department of Neurologic Surgery.
Juan M Rojas Cabrera1Department of Neurologic Surgery.
Hojin Shin1Department of Neurologic Surgery.
Su-Youne Chang1Department of Neurologic Surgery.
Christopher J Kimble3Division of Engineering, and.
Kevin E Bennet1Department of Neurologic Surgery.
Charles D Blaha1Department of Neurologic Surgery.
Kendall H Lee1Department of Neurologic Surgery.
Yoonbae Oh1Department of Neurologic Surgery.

Funding

Medical Scientist Traning Program at Mayo ClinicT32GM065841 · NIGMS · MAYO CLINIC ROCHESTER · PI KAUFMANN, SCOTT H, SCHIMMENTI, LISA A · 2003 to 2022
$5.8M
Astrocytic function in DBS for essential tremorR01NS088260 · NINDS · MAYO CLINIC ROCHESTER · PI CHANG, SU-YOUNE · 2015 to 2019
$1.7M
Development of advanced voltammetric method for basal neurotransmitter level measurementR01NS112176 · NINDS · MAYO CLINIC ROCHESTER · PI LEE, KENDALL H., OH, YOONBAE · 2019 to 2022
$1.4M
Mechanism of CMPf Deep Brain Stimulation for Tourette SyndromeF31NS115202 · NINDS · MAYO CLINIC ROCHESTER · PI RUSHEEN, AARON ELLIOTT · 2020 to 2023
$195k
NIGMS NIH HHS T32 GM065841NINDS NIH HHS F31 NS115202NINDS NIH HHS R01 NS088260NINDS NIH HHS R01 NS112176
6 · The paper itself

Abstract

The development of closed-loop deep brain stimulation (DBS) systems represents a significant opportunity for innovation in the clinical application of neurostimulation therapies. Despite the highly dynamic nature of neurological diseases, open-loop DBS applications are incapable of modifying parameters in real time to react to fluctuations in disease states. Thus, current practice for the designation of stimulation parameters, such as duration, amplitude, and pulse frequency, is an algorithmic process. Ideal stimulation parameters are highly individualized and must reflect both the specific disease presentation and the unique pathophysiology presented by the individual. Stimulation parameters currently require a lengthy trial-and-error process to achieve the maximal therapeutic effect and can only be modified during clinical visits. The major impediment to the development of automated, adaptive closed-loop systems involves the selection of highly specific disease-related biomarkers to provide feedback for the stimulation platform. This review explores the disease relevance of neurochemical and electrophysiological biomarkers for the development of closed-loop neurostimulation technologies. Electrophysiological biomarkers, such as local field potentials, have been used to monitor disease states. Real-time measurement of neurochemical substances may be similarly useful for disease characterization. Thus, the introduction of measurable neurochemical analytes has significantly expanded biomarker options for feedback-sensitive neuromodulation systems. The potential use of biomarker monitoring to advance neurostimulation approaches for treatment of Parkinson's disease, essential tremor, epilepsy, Tourette syndrome, obsessive-compulsive disorder, chronic pain, and depression is examined. Further, challenges and advances in the development of closed-loop neurostimulation technology are reviewed, as well as opportunities for next-generation closed-loop platforms.

Indexed as

Deep Brain StimulationBrainEssential TremorHumansNervous System DiseasesObsessive-Compulsive DisorderParkinson DiseaseTourette SyndromeACC = anterior cingulate cortexALIC = anterior limb of the internal capsuleclosed loopCM-Pf = centromedian-parafascicular complexDBS = deep brain stimulationdeep brain stimulationelectrochemistryelectrophysiologyET = essential tremorFSCV = fast-scan cyclic voltammetryGABA = gamma-aminobutyric acidGPi = globus pallidus internaLFP = local field potentialNAc = nucleus accumbensneurochemical measurementOCD = obsessive-compulsive disorderopen loopPAG = periaqueductal grayPD = Parkinson’s diseasePVG = periventricular gray matterSANTE = Stimulation of the Anterior Nucleus of the Thalamus for EpilepsySTN = subthalamic nucleusTS = Tourette syndromeVC = ventral capsuleVPL = ventral posterolateral nucleusVPM = ventral posteromedial nucleusVS = ventral striatumvT = ventral thalamusWINCS = Wireless Instantaneous Neurotransmitter Concentration Sensing

Identifiers

PMID32610297
PMCPMC7478171

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.